Wells Fargo’s Nexalin Technology NXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$330 Hold
33
﹤0.01% 6554
2026
Q1
$348 Buy
+33
New +$515 ﹤0.01% 6425
2025
Q2
Sell
-20
Closed -$1.17K 7297
2025
Q1
$1.17K Hold
20
﹤0.01% 6224
2024
Q4
$1.66K Buy
+20
New +$1.67K ﹤0.01% 6209
2024
Q2
Sell
-1
Closed -$62 7294
2024
Q1
$62 Hold
1
﹤0.01% 6777
2023
Q4
$17 Hold
1
﹤0.01% 7262
2023
Q3
$18 Hold
1
﹤0.01% 7238
2023
Q2
$15 Hold
1
﹤0.01% 7367
2023
Q1
$13 Hold
1
﹤0.01% 7466
2022
Q4
$12 Buy
+1
New +$46 ﹤0.01% 7364

Other funds holding NXL

Wells Fargo's NXL Position: Q2 2026 in Review

Wells Fargo held its Nexalin Technology (NXL) position steady in Q2 2026 at 33 shares worth $330. The position accounts for ﹤0.01% of the portfolio, ranked #6554.

Wells Fargo first reported a position in NXL in Q4 2022 and has held it in 10 quarters since. The position peaked at $1.66K in Q4 2024. 20 funds tracked by Wall St. Rank hold NXL as of Q2 2026.

  • Wells Fargo held 33 shares of Nexalin Technology worth $330 as of Q2 2026.
  • Wells Fargo left its Nexalin Technology share count unchanged in Q2 2026.
  • Nexalin Technology made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6554 holding.
  • Wells Fargo first reported a position in Nexalin Technology in Q4 2022 and has held it in 10 quarters since.
  • Wells Fargo's Nexalin Technology position peaked at $1.66K in Q4 2024.
  • 20 funds tracked by Wall St. Rank held Nexalin Technology as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.